About CPF
Company Profiles
Awards
Global Collaboration
Media Center
Subsidiary
Products & Services
API and intermediates
Dosage
Services
R&D
News
Company News
Industry News
Contact Us
中
About CPF
Products & Services
R&D
News
Contact Us
API and intermediates
Dosage
Services
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No.
Dosage
Strength
Indication
1
Upadacitinib
Amorphous/Form C
12.3-13.6kg
1
